On November 3, the FDA will host an unprecedented discussion between the diabetes community and senior agency leadership (both drugs and devices). The event will be live webcast from 1 – 4 pm. This event should be nothing short of a home run.
The event will include a panel of patients (T1 and T2), as well as representatives from ADA, JDRF, and diaTribe. As a community, our job is to present the numerous challenges diabetes patients face each day, and we need as many opinions as possible to be a part of this discussion!
With FDA, ADA, JDRF, and dQ&A input, diaTribe has created a survey posted at www.diaTribe.org/survey.
The entire diabetes community (T1 and T2!) is invited to fill out this short survey and share thoughts on what’s important when it comes to living with diabetes. This feedback will go directly to FDA and help influence the conversation on November 3.